SBIR/STTR Research Award

Isothermal Amplification for Detection of Nucleic Acids

Award identifier 83513bb2a6071dc425be803332ecb4751c9831d571d3fa3d22eefbcfdd489869Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$96,594

Program and phase

SBIR · Phase I

Award year

2001

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
ACTIVE MOTIF, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
N7GVF5GCF3A6
Solicitation number
Not reported
Topic code
Not reported

Research abstract

In this proposal we discuss the development of a technique to amplify the signal generated when a labeled chimeric oligonucleotide hybridizes to it target sequence. Clearly there is a huge need for such a technique given the amount of variability that occurs during triditional amplification reactions, such as PCR. The chimeric oligonucleotide described in this proposal binds to it target sequence and becomes the subtrate for a specific endonuclease. Following degradation of the bound chimeric oligonucleotide, another oligonucleotide binds to the same sequence and this again becomes a target for degradation. Thus, the signal is amplified by many rounds of binding and degradation. The amplification and detection are performed entirely in solution in a single reaction tube with no reagent additions during the reaction. In Phase II of this study, we hope to develop this technology into a Kit that would be suitable to clinical applications, such as detecting bacterial or viral DNA in blood, plasma and other biological samples. PROPOSED COMMERCIAL APPLICATION: The successful completion of this study would result in a technology for amplifying a signal generated when a chimeric molecular beacon hybridizes to a target DNA in a mixed nucleic acid population. The commercial applications for this type of technology are vast including numerous clinical applications (diagnostic and prognostic) that would enable detection of particular viral (e.g. CMV or EBV), OR bacterial (e.g. Helicobacter Pylori, or Mycobacterium tuberculosis) sequences in human tissues or cell culture. Active Motif would make these reagents available to the research community.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

23 SBIR/STTR records share this UEI (2001–2025). Reported award amounts total $5,925,376. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, National Science Foundation

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.